lobbying_activities: 2824633

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2824633	b4bf3c99-3a71-4b61-bb67-d1165b3c9509	Q2	DANA-FARBER CANCER INSTITUTE	401106163	DANA-FARBER CANCER INSTITUTE	2022	second_quarter	MED	Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including HR5030 / S2706 - The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; HR623 / S1521 - Gabriella Miller Kids First Research Act 2.0; HR3089 / S1544 Accelerating Kids Access to Care Act; HR 6000, CURES 2.0 Act; H.R. 5585, the Advanced Research Project Agency-Health (ARPA-H) Act	HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE		78000	0	0	2022-07-18T14:24:02-04:00